[Bleomycin, a new antitumour antibiotic in the treatment of neoplastic diseases].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use / Q000633:toxicity; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D055598:Chemical Phenomena; D002621:Chemistry; D004273:DNA, Neoplasm / Q000037:antagonists & inhibitors; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006801:Humans; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D010412:Penile Neoplasms / Q000188:drug therapy; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012878:Skin Neoplasms / Q000188:drug therapy; D012888:Skull Neoplasms / Q000188:drug therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy
D000903:Antibiotics, Antineoplastic; D004273:DNA, Neoplasm; D001761:Bleomycin
Bleomycin, ein neues Antitumor-Antibiotikum zur Behandlung neoplastischer Krankheiten.